Jennifer A. Galvin, MD
Director, Pediatric Ophthalmology and StrabismusDownloadHi-Res Photo
About
Copy Link
Titles
Director, Pediatric Ophthalmology and Strabismus; Principal Investigator, Yale site for PEDIG (Pediatric Eye Disease Investigator Group)
Departments & Organizations
Education & Training
- Fellowship
- Universtiy of Michigan Health System (2009)
- Residency
- Eastern Virginia Medical School (2008)
- Internship
- Resurrection Medical Center (2005)
- Fellowship
- University of Illinois Chicago (2004)
- MD
- Wayne State University (2003)
- MA
- Harvard University (1999)
- BA
- University of Notre Dame (1995)
Research
Copy Link
Research at a Glance
Publications Timeline
A big-picture view of Jennifer A. Galvin's research output by year.
9Publications
187Citations
Publications
2023
Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion
Della Rocca D, Magnocavallo M, Van Niekerk C, Gilhofer T, Ha G, D'Ambrosio G, Mohanty S, Gianni C, Galvin J, Vetta G, Lavalle C, Di Biase L, Sorgente A, Chierchia G, de Asmundis C, Urbanek L, Schmidt B, Geller J, Lakkireddy D, Mansour M, Saw J, Horton R, Gibson D, Natale A. Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion. EP Europace 2023, 25: euad315. PMID: 37889200, PMCID: PMC10653166, DOI: 10.1093/europace/euad315.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsChronic kidney diseaseChronic kidney disease stage 4Chronic kidney disease stage 3Chronic kidney disease stage 5Prognostic valueMajor bleedingAppendage occlusionThrombo-EmbolismPrimary endpointAtrial fibrillationPercutaneous left atrial appendage occlusionKidney diseaseChronic kidney disease stages 1Estimated glomerular filtration rateLeft atrial appendage occlusionChronic kidney disease groupConsecutive AF patientsHAS-BLED scoreModerate-to-severe CKDPeri-procedural adverse eventsRisk of thrombo-embolismPrimary composite endpointGlomerular filtration rateFollow-up periodIncidence of TEOutcomes of Patients With Takotsubo Syndrome Compared With Type 1 and Type 2 Myocardial Infarction
Khaloo P, Ledesma P, Nahlawi A, Galvin J, Ptaszek L, Ruskin J. Outcomes of Patients With Takotsubo Syndrome Compared With Type 1 and Type 2 Myocardial Infarction. Journal Of The American Heart Association 2023, 12: e030114. PMID: 37681546, PMCID: PMC10547303, DOI: 10.1161/jaha.123.030114.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsType 1 MIType 2 MITakotsubo syndromeMyocardial infarctionRisk of ventricular arrhythmiasType 2 myocardial infarctionOutcomes of patientsRates of in-hospital mortalityIn-Hospital MortalityNational Readmission DatabaseRisk of mortalityNational Inpatient SampleLaboratory characteristicsVentricular arrhythmiasVentricular tachycardiaCardiac arrestConclusions PatientsVentricular fibrillationReadmissions DatabasePatientsObservational studyType 1Inpatient SampleMortality rateReadmission rates
2022
Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device–Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017
Khaloo P, Uzomah U, Shaqdan A, Ledesma P, Galvin J, Ptaszek L, Ruskin J. Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device–Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017. Journal Of The American Heart Association 2022, 11: e025600. PMID: 36000421, PMCID: PMC9496407, DOI: 10.1161/jaha.122.025600.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsNative valve endocarditisProsthetic valve endocarditisNational (Nationwide) Inpatient SampleDevice-related infective endocarditisLength of stayOutcomes of patientsValve endocarditisInfective endocarditisMortality ratePopulation-based dataHospital costsHospital lengthStudy periodIn-hospital mortality rateHospital length of staySingle-center studyIn-Hospital MortalityHigher hospital costsUnited StatesNationwide studyInpatient SamplePatient sample sizeEndocarditisHospital
2021
Distinct etiologies of high-sensitivity troponin T elevation predict different mortality risks for patients hospitalized with COVID-19
Khaloo P, Shaqdan A, Ledesma P, Uzomah U, Galvin J, Ptaszek L, Ruskin J. Distinct etiologies of high-sensitivity troponin T elevation predict different mortality risks for patients hospitalized with COVID-19. International Journal Of Cardiology 2021, 351: 118-125. PMID: 34952038, PMCID: PMC8690225, DOI: 10.1016/j.ijcard.2021.12.029.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHs-TnT elevationNon-cardiac etiologyElevated hs-TnTHs-TnTCardiac etiologyPrimary cardiac etiologyCOVID-19 infectionCardiovascular eventsElevated high-sensitivity troponinElevated hs-TnT levelsMortality riskHs-TnT levelsRisk of negative patient outcomesAcute heart failureHigh-sensitivity troponinRetrospective chart reviewTroponin T elevationPredictors of mortalityLogistic regression analysisRisk of mortalitySensitive troponinRenal failureChart reviewT elevationHeart failureIncidence of carditis and predictors of pacemaker implantation in patients hospitalized with Lyme disease
Uzomah U, Rozen G, Hosseini S, Shaqdan A, Ledesma P, Yu X, Khaloo P, Galvin J, Ptaszek L, Ruskin J. Incidence of carditis and predictors of pacemaker implantation in patients hospitalized with Lyme disease. PLOS ONE 2021, 16: e0259123. PMID: 34731187, PMCID: PMC8565769, DOI: 10.1371/journal.pone.0259123.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCardiac conduction system diseasePermanent pacemaker implantationConduction system diseasePredictors of permanent pacemaker implantationPacemaker implantationLyme carditisSystemic diseaseClinical manifestationsPredictors of pacemaker implantationIn-hospital mortality rateCardiac conduction diseaseTemporary cardiac pacingComplete heart blockIncidence of carditisRetrospective cohort analysisSinoatrial node dysfunctionInfection of cardiac tissueIn-Hospital MortalityManifestation of Lyme carditisLyme diseasePrimary study outcomeNationwide Inpatient SampleConduction diseaseAcute myocarditisAcute pericarditisMAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device
Ledesma P, Uzomah U, Yu X, Shaqdan A, Khaloo P, Galvin J, Mansour M, Ptaszek L, Ruskin J. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device. The American Journal Of Cardiology 2021, 152: 78-87. PMID: 34116792, DOI: 10.1016/j.amjcard.2021.04.015.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAtrial AppendageAtrial FibrillationCardiac Surgical ProceduresCardiac TamponadeDatabases, FactualDevice ApprovalEquipment FailureHumansHypotensionIntraoperative ComplicationsMortalityPericardial EffusionPostoperative ComplicationsProstheses and ImplantsProsthesis FailureProsthesis ImplantationStrokeThrombosisTime FactorsConceptsLeft atrial appendage closureAtrial appendage closureAdverse eventsWatchman implantationDevice embolizationAppendage closureAtrial fibrillationNon-valvular atrial fibrillationWatchman LAAC deviceOverall adverse event rateEvent ratesLong-term anticoagulationStudy periodUnique adverse eventsAdverse event ratesAbsolute event ratesUser Facility Device ExperienceLAAC deviceReal-world assessmentPericardial effusionStroke riskWatchman deviceDevice implantationClinical trialsFDA approval
2019
WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage
Hucker W, Cohen J, Gurol M, Heist E, Gianni C, Galvin J, Atkins D, Bommana S, Di Biase L, Ruskin J, Mohanty S, Horton R, Lakkireddy D, Natale A, Mansour M. WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage. Journal Of Interventional Cardiac Electrophysiology 2019, 59: 415-421. PMID: 31833012, DOI: 10.1007/s10840-019-00678-w.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsHistory of intracranial hemorrhageGroup I patientsDual antiplatelet therapyIntracranial hemorrhageWatchman implantationOral anticoagulantsI patientsGroup IIWatchman placementGroup IMulticenter seriesPost-procedureDAPT therapyMulticenter series of patientsPrimary outcomeHistory of atrial fibrillationLeft atrial appendage closureAssociated with high mortality ratesMonths post-procedureSeries of patientsRecurrent intracranial hemorrhageAtrial fibrillation patientsAnti-thrombotic therapyAtrial appendage closureHigher mortality rateSafety and In-Hospital Outcomes of Transvenous Lead Extraction for Cardiac Implantable Device–Related Infections Analysis of 13 Years of Inpatient Data in the United States
Hosseini S, Rozen G, Kaadan M, Galvin J, Ruskin J. Safety and In-Hospital Outcomes of Transvenous Lead Extraction for Cardiac Implantable Device–Related Infections Analysis of 13 Years of Inpatient Data in the United States. JACC Clinical Electrophysiology 2019, 5: 1450-1458. PMID: 31857046, DOI: 10.1016/j.jacep.2019.08.020.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsIn-Hospital OutcomesDevice-related infectionsInternational ClassificationPredictors of mortalityNational (Nationwide) Inpatient SampleCongestive heart failureChronic kidney diseaseLead extractionIn-hospital mortality rateIndependent predictorsIndependent predictor of mortalityAdverse eventsTranscutaneous lead extractionHeart failureOutcomes of transvenous lead extractionKidney diseaseRates of device-related infectionsUnited StatesInpatient SampleCardiac implantable electronic device implantationAssociated with device-related infectionsIn-HospitalRate of complicationsTransvenous lead extractionCardiac implantable electronic devicesA comparison of postprocedural anticoagulation in high‐risk patients undergoing WATCHMAN device implantation
Cohen J, Heist E, Galvin J, Lee H, Johnson M, Fitzsimons M, Slattery K, Ghoshhajra B, Sakhuja R, Ha G, Forsch M, Shi L, Danik J, Dal‐Bianco J, Sanborn D, Hung J, Ruskin J, Gurol M, Mansour M. A comparison of postprocedural anticoagulation in high‐risk patients undergoing WATCHMAN device implantation. Pacing And Clinical Electrophysiology 2019, 42: 1304-1309. PMID: 31479160, DOI: 10.1111/pace.13796.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLeft atrial appendage closureHigh-risk patientsAtrial fibrillationWatchman deviceComposite endpointDevice implantationHigh-risk patient populationComposite endpoint of strokeWatchman device implantationEfficacy of warfarinLong-term anticoagulationShort-term anticoagulationAtrial appendage closureIncidence of deathEndpoint of strokeNOAC useThromboembolic protectionRandomized Controlled TrialsPostprocedural anticoagulationWarfarin useMajor bleedingBleeding riskEfficacy analysisHemorrhagic eventsNo significant difference
Academic Achievements & Community Involvement
Copy Link
Honors
honor Heed Ophthalmic Foundation Fellow
06/30/2009National AwardThe Heed Ophthalmic FoundationDetailsUnited States
Get In Touch
Copy Link